A Johns Hopkins Children’s Center study in mice may help explain why women are more prone than men to a form of liver damage by implicating the female sex hormone estrogen in the development of autoimmune hepatitis.
New research, conducted on rodents, suggests that pre-menopausal hysterectomy with ovariectomy induces changes in the hippocampus (memory center of brain) making it hypersensitive to ischemic stressors (reduced blood flow). In contrast, ischemic stressors did not cause hippocampal damage in non-ovariectomized female rats or even gonadectomized male rats.
Estradiol is used to treat symptoms of menopause such as hot flashes, and vaginal dryness, burning, and irritation. Other uses include prevention of osteoporosis in postmenopausal women, and replacement of estrogen in women with ovarian failure or other conditions that cause a lack of natural estrogen in the body.
DES is an example of an uncontrolled medical experiment gone wrong. And how many generations ago was that – and women are still affected by adverse reactions? DES should be a wake up call for women on synthetic hormones… and who are considering getting the HPV vaccine, Gardasil or Cervarix. Mark my words these vaccines will go down as the DES of the 21st century.
Hormones and/or hormone-mimicking chemicals are omnipresent environmental contaminants. Already found in places as varied as our teeth (dental sealant) to our paper products (receipts, money), our meat to our canned foods, new research now indicates that even fresh, whole vegetables and fruits are no longer immune to this growing biological and chemical threat.
Our purpose here first is to put women’s midlife concerns into a new and more accurate hormonal picture. Specifically, I’d like to present new information about high estrogen levels in the perimenopause. Not low, not even normal, but estrogen levels that are higher than those of the (sexiest) 20 year old female!
October 9, 2012 (Orlando, Florida) — Postmenopausal women have higher rates of vaginal atrophy in the United States than in other countries, in large part because they refuse to consider remedies such as local estrogen therapy, according to a survey presented here at the North American Menopause Society (NAMS) 23rd Annual Meeting.